|
|
|
Volumn 13, Issue 2, 1994, Pages 292-296
|
|
Diltiazem improves cyclosporine dosage in cystic fibrosis lung transplant recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
CYCLOSPORIN;
DILTIAZEM;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
CREATININE BLOOD LEVEL;
CYSTIC FIBROSIS;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG EFFICACY;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG TRANSPLANTATION;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
CYCLOSPORINE;
CYSTIC FIBROSIS;
DILTIAZEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
HEMODYNAMIC PROCESSES;
HUMANS;
LUNG TRANSPLANTATION;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 0028212196
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
